Annual SGA
$2.18 M
+$2000.00+0.09%
December 31, 2023
Summary
- As of February 10, 2025, MACK annual SGA is $2.18 million, with the most recent change of +$2000.00 (+0.09%) on December 31, 2023.
- During the last 3 years, MACK annual SGA has fallen by -$2.84 million (-56.58%).
Performance
MACK SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly SGA
$669.00 K
+$179.00 K+36.53%
March 1, 2024
Summary
- As of February 10, 2025, MACK quarterly SGA is $669.00 thousand, with the most recent change of +$179.00 thousand (+36.53%) on March 1, 2024.
- Over the past year, MACK quarterly SGA has increased by +$138.00 thousand (+25.99%).
Performance
MACK Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM SGA
-$1.99 B
+$200.46 M+9.14%
March 1, 2024
Summary
- As of February 10, 2025, MACK TTM SGA is -$1.99 billion, with the most recent change of +$200.46 million (+9.14%) on March 1, 2024.
- Over the past year, MACK TTM SGA has dropped by -$2.00 billion (-87022.76%).
Performance
MACK TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
MACK Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.1% | +26.0% | -10000.0% |
| 3 y3 years | -56.6% | +26.0% | -10000.0% |
| 5 y5 years | -86.0% | +26.0% | -10000.0% |
MACK Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -16.8% | -0.1% | at high | -29.3% | at high | +10.1% |
| 5 y | 5-year | -86.5% | -0.1% | -69.7% | -29.3% | at high | +10.1% |
| alltime | all time | -93.2% | -0.1% | -96.1% | -2254.3% | +633.8% | +88.3% |
Merrimack Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $669.00 K(+36.5%) | $2.26 M(+3.8%) |
| Dec 2023 | $2.18 M(+0.1%) | $490.00 K(-7.7%) | $2.18 M(-5.1%) |
| Sep 2023 | - | $531.00 K(-6.7%) | $2.29 M(+1.2%) |
| Jun 2023 | - | $569.00 K(-2.9%) | $2.27 M(+3.8%) |
| Mar 2023 | - | $586.00 K(-3.5%) | $2.18 M(+0.4%) |
| Dec 2022 | $2.17 M(-16.9%) | $607.00 K(+20.4%) | $2.17 M(+6.6%) |
| Sep 2022 | - | $504.00 K(+3.7%) | $2.04 M(-5.3%) |
| Jun 2022 | - | $486.00 K(-15.8%) | $2.15 M(-11.9%) |
| Mar 2022 | - | $577.00 K(+22.0%) | $2.45 M(-6.5%) |
| Dec 2021 | $2.62 M(-47.8%) | $473.00 K(-23.6%) | $2.62 M(-13.6%) |
| Sep 2021 | - | $619.00 K(-20.4%) | $3.03 M(-11.4%) |
| Jun 2021 | - | $778.00 K(+4.3%) | $3.42 M(-10.6%) |
| Mar 2021 | - | $746.00 K(-15.8%) | $3.82 M(-23.7%) |
| Dec 2020 | $5.01 M(-69.0%) | $886.00 K(-12.0%) | $5.01 M(-20.9%) |
| Sep 2020 | - | $1.01 M(-14.9%) | $6.34 M(-34.5%) |
| Jun 2020 | - | $1.18 M(-38.8%) | $9.68 M(-32.9%) |
| Mar 2020 | - | $1.94 M(-12.5%) | $14.42 M(-10.8%) |
| Dec 2019 | $16.17 M(+3.6%) | $2.21 M(-49.1%) | $16.17 M(-10.2%) |
| Sep 2019 | - | $4.35 M(-26.7%) | $18.00 M(+3.3%) |
| Jun 2019 | - | $5.93 M(+61.0%) | $17.43 M(+16.1%) |
| Mar 2019 | - | $3.68 M(-8.9%) | $15.01 M(-3.8%) |
| Dec 2018 | $15.60 M(-45.2%) | $4.04 M(+7.0%) | $15.60 M(-3.8%) |
| Sep 2018 | - | $3.78 M(+7.5%) | $16.21 M(+2.6%) |
| Jun 2018 | - | $3.51 M(-17.7%) | $15.80 M(-41.7%) |
| Mar 2018 | - | $4.27 M(-8.3%) | $27.09 M(-4.8%) |
| Dec 2017 | $28.45 M(-11.2%) | $4.65 M(+38.3%) | $28.45 M(-18.3%) |
| Sep 2017 | - | $3.37 M(-77.3%) | $34.81 M(-8.1%) |
| Jun 2017 | - | $14.80 M(+162.7%) | $37.89 M(+21.3%) |
| Mar 2017 | - | $5.63 M(-48.8%) | $31.23 M(-2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $32.05 M(+33.3%) | $11.01 M(+70.8%) | $32.05 M(+383.7%) |
| Sep 2016 | - | $6.45 M(-20.8%) | $6.63 M(-61.3%) |
| Jun 2016 | - | $8.14 M(+26.1%) | $17.13 M(-19.6%) |
| Mar 2016 | - | $6.45 M(-144.8%) | $21.31 M(-11.4%) |
| Dec 2015 | $24.05 M(-21.2%) | -$14.41 M(-185.0%) | $24.05 M(-48.5%) |
| Sep 2015 | - | $16.96 M(+37.7%) | $46.74 M(+23.4%) |
| Jun 2015 | - | $12.31 M(+34.0%) | $37.88 M(+13.1%) |
| Mar 2015 | - | $9.19 M(+11.0%) | $33.48 M(+9.7%) |
| Dec 2014 | $30.52 M(+44.0%) | $8.28 M(+2.2%) | $30.52 M(+8.0%) |
| Sep 2014 | - | $8.10 M(+2.2%) | $28.25 M(+11.6%) |
| Jun 2014 | - | $7.92 M(+27.3%) | $25.30 M(+12.6%) |
| Mar 2014 | - | $6.22 M(+3.6%) | $22.48 M(+6.1%) |
| Dec 2013 | $21.19 M(+34.1%) | $6.01 M(+16.7%) | $21.19 M(+9.6%) |
| Sep 2013 | - | $5.15 M(+1.1%) | $19.33 M(+4.5%) |
| Jun 2013 | - | $5.09 M(+3.3%) | $18.49 M(+8.7%) |
| Mar 2013 | - | $4.93 M(+18.7%) | $17.01 M(+7.6%) |
| Dec 2012 | $15.80 M(+9.3%) | $4.16 M(-3.6%) | $15.80 M(+6.3%) |
| Sep 2012 | - | $4.31 M(+19.4%) | $14.87 M(+7.3%) |
| Jun 2012 | - | $3.61 M(-3.2%) | $13.86 M(-8.1%) |
| Mar 2012 | - | $3.73 M(+16.0%) | $15.08 M(+4.3%) |
| Dec 2011 | $14.45 M(+27.0%) | $3.21 M(-2.8%) | $14.45 M(+2.8%) |
| Sep 2011 | - | $3.31 M(-31.6%) | $14.06 M(+1.3%) |
| Jun 2011 | - | $4.83 M(+55.8%) | $13.88 M(+15.4%) |
| Mar 2011 | - | $3.10 M(+9.7%) | $12.03 M(+5.7%) |
| Dec 2010 | $11.38 M(-6.5%) | $2.83 M(-9.5%) | $11.38 M(+33.0%) |
| Sep 2010 | - | $3.12 M(+4.8%) | $8.55 M(+57.5%) |
| Jun 2010 | - | $2.98 M(+21.4%) | $5.43 M(+121.4%) |
| Mar 2010 | - | $2.45 M | $2.45 M |
| Dec 2009 | $12.18 M | - | - |
FAQ
- What is Merrimack Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals annual SGA year-on-year change?
- What is Merrimack Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals quarterly SGA year-on-year change?
- What is Merrimack Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals TTM SGA year-on-year change?
What is Merrimack Pharmaceuticals annual SGA?
The current annual SGA of MACK is $2.18 M
What is the all time high annual SGA for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high annual SGA is $32.05 M
What is Merrimack Pharmaceuticals annual SGA year-on-year change?
Over the past year, MACK annual SGA has changed by +$2000.00 (+0.09%)
What is Merrimack Pharmaceuticals quarterly SGA?
The current quarterly SGA of MACK is $669.00 K
What is the all time high quarterly SGA for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high quarterly SGA is $16.96 M
What is Merrimack Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, MACK quarterly SGA has changed by +$138.00 K (+25.99%)
What is Merrimack Pharmaceuticals TTM SGA?
The current TTM SGA of MACK is -$1.99 B
What is the all time high TTM SGA for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high TTM SGA is -$271.62 M
What is Merrimack Pharmaceuticals TTM SGA year-on-year change?
Over the past year, MACK TTM SGA has changed by -$2.00 B (-87022.76%)